Pricing and mixnegative · 5 filings
“This decrease was partially offset by higher pricing and volumes of existing products in certain Middle Eastern and Asian countries.”10-Q · Aug 6, 2026 ↗
Viatris Inc.
VTRS
Market read
Viatris Inc.'s current read is isolated; its market group is not confirming.
No new filing conclusion is available. 0 of 37 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 15 directly disclosed connections are confirming.
Company+0.8% todayVolume comparison unavailable
Market group0 of 37 activeNo Coherent Theme · unavailable
Disclosed network0 of 8 confirmingNo filing-linked name is confirming now
What would change this read
Watch this read- Constant-currency net sales fell ~$6.6M (2%) vs prior year for existing products in Japan and Australia due to government price reductions and additional competition.
Invalidation: The isolated read changes if VTRS's group or a disclosed connection begins moving with it.
Research brief
The story so far
No new filing conclusion is available. 0 of 37 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 15 directly disclosed connections are confirming.
Evidence that supports
No thresholded supportive filing evidence is available yet.
Evidence that challenges
No thresholded adverse filing evidence is available yet.
What would clarify the read
- Constant-currency net sales fell ~$6.6M (2%) vs prior year for existing products in Japan and Australia due to government price reductions and additional competition.
Company research
Understand the business, not just the ticker
Business model and earnings drivers
Use the company’s filings to identify the few operating, demand, cost, capital and regulatory variables that determine its earnings power.
Key research questions
- Which operating variable is changing?
- Is that change durable, cyclical or one-off?
- What evidence would disprove the current interpretation?
Annual periods8
Price observations602
Usable filing statements139
Verified relationships9
Evidence supporting the case
No qualifying supportive evidence was identified.
Evidence challenging the case
- Latest annual revenue changed -3.0% year over year.
- Operating margin changed -18.8 percentage points in the latest annual period.
- Pricing and mix has repeated adverse evidence across 5 filings.
- Product pipeline and R&D has repeated adverse evidence across 5 filings.
- Restructuring and cost reductions has repeated adverse evidence across 5 filings.
Questions before a position
No credible peer-relative valuation comparison is available yet.
Longer-term price context
Price as of Sep 11, 2026
16.526m+19.7%12m+61.3%24m+46.7%
Annual trajectory
Reported annual revenue and per-share history. This is accounting history, not a forecast.
PeriodRevenueYoYDiluted EPSShare change
2021-12-31$17.8B+50.7%$-1.05—
2022-12-31$16.2B-9.0%$1.71+0.7%
2023-12-31$15.4B-5.1%$0.05-0.9%
2024-12-31$14.7B-4.5%$-0.53—
2025-12-31$14.3B-3.0%$-3.00—
What management says matters
Persistent and emerging business drivers
Product pipeline and R&Dnegative · 5 filings
“Constant currency net sales decreased by approximately $8.0 million, or 1%, when compared to the prior year period, driven primarily by lower net sales of existing products in Australia due to additional competition, partially offset by new product sales.”10-Q · Aug 6, 2026 ↗
Restructuring and cost reductionsnegative · 5 filings
“The benefit in the prior year period is primarily driven by the loss before income taxes, partially offset by the negative impact of the goodwill impairment charge, for which minimal tax benefit was realized, and a $17.7 million accrual related to the resolut…”10-Q · Aug 6, 2026 ↗
Demand and volumemixed · 3 filings
“These increases were partially offset by lower volumes in our ARV business, mainly as a result of the Indore Impact of approximately $77 million.”10-K · Feb 26, 2026 ↗
Valuation discipline
Descriptive valuation snapshot
Price/sales — · EV/sales —. Comparisons use only industry-matched filing peers.
Scenario scaffold
No usable price/earnings or price/sales multiple (need a fresh price).
Price action
How the market is pricing the story
16.52+0.8% today
Jodie does not have enough daily observations to draw a useful short-term chart for this asset. The latest quoted price was checked 11 Sept, 15:55 GMT-4; this is a coverage limitation, not a flat-price conclusion.
Developments
No sourced recent-development timeline yet
Jodie has not returned a relevant primary source or news item for VTRS. This is an evidence-coverage gap, not a conclusion that nothing material happened.
Business and financial condition
Reported financial figures are not available yet
Jodie has not returned structured SEC XBRL fundamentals for this asset. This is a coverage limitation, not an assessment of the business or its financial health.
Filing analysis
No comparable filing assessment is available yet
Jodie has not yet found a suitable current-versus-prior filing comparison for VTRS. This does not mean the latest filing was neutral or immaterial.
Business ecosystem
The relationships behind VTRS
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
TBPHTheravance Biopharma, Inc.partnerFeb 26, 2026 ▾
“Theravance Biopharma The Company has a development and commercialization collaboration with Theravance Biopharma, for revefenacin.”
Depended on by
TBPHTheravance Biopharma, Inc.partnerMay 7, 2026 ▾
“The stability of revefenacin in both metered dose inhaler and dry powder inhaler (“MDI/DPI”) formulations suggests that revefenacin could also serve as a foundation for novel handheld combination products.”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 17 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
VTRS is currently a Participant in the organic co-movement group No Coherent Theme. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 2 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.
This group is retained as the last observed read for VTRS; it is not active in the latest market snapshot.
Context history
Theme membership history
No durable theme membership has been observed for this name yet.